Xiao JW, Liu ZL, Ye PC, Luo YJ, Fu ZM, Zou Q, Wei SJ. Clinical comparison of antrum-preserving double tract reconstruction vs roux-en-Y reconstruction after gastrectomy for Siewert types II and III adenocarcinoma of the esophagogastric junction. World J Gastroenterol 2015; 21(34): 9999-10007 [PMID: 26379405 DOI: 10.3748/wjg.v21.i34.9999]
Corresponding Author of This Article
Jiang-Wei Xiao, MD, PhD, Professor, Department of General Surgery, the Affiliated Hospital of North Sichuan Medical College, Nanchong 637000, Sichuan province, China. xiaojiangwei@126.com
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Retrospective Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastroenterol. Sep 14, 2015; 21(34): 9999-10007 Published online Sep 14, 2015. doi: 10.3748/wjg.v21.i34.9999
Clinical comparison of antrum-preserving double tract reconstruction vs roux-en-Y reconstruction after gastrectomy for Siewert types II and III adenocarcinoma of the esophagogastric junction
Jiang-Wei Xiao, Zi-Lin Liu, Peng-Cheng Ye, Ya-Jun Luo, Zhi-Ming Fu, Shou-Jiang Wei, Department of General Surgery, the Affiliated Hospital of North Sichuan Medical College, Nanchong 637000, Sichuan Province, China
Qin Zou, West China Hospital/West China School of Nursing, Sichuan University, Chengdu 610041, Sichuan Province, China
Author contributions: Xiao JW, Liu ZL and Wei SJ designed the study; Xiao JW, Liu ZL, Ye PC, Luo YJ, Fu ZM and Wei SJ performed the research; Xiao JW, Liu ZL and Zou Q analyzed the data; Liu ZL and Xiao JW wrote the manuscript; Liu ZL and Xiao JW contributed equally to this study and shared the first authorship.
Supported by Grants from Sichuan Provincial Department of Education Research Project, No. 14ZA0192; and National Natural Science Foundation of China, No. 30700773, No. 81070378, and No. 81270561.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Jiang-Wei Xiao, MD, PhD, Professor, Department of General Surgery, the Affiliated Hospital of North Sichuan Medical College, Nanchong 637000, Sichuan province, China. xiaojiangwei@126.com
Telephone: +86-13890868466 Fax: +86-817-2262417
Received: February 27, 2015 Peer-review started: March 1, 2015 First decision: April 13, 2015 Revised: April 23, 2015 Accepted: July 15, 2015 Article in press: July 15, 2015 Published online: September 14, 2015
Core Tip
Core tip: Antrum-preserving double-tract reconstruction (ADTR) was introduced to improve the near-term quality of life and decrease reflux esophagitis in patients with adenocarcinoma of the esophagogastric junction. The clinicopathological characteristics, perioperative outcomes, postoperative complications, morbidity and overall survival after ADTR and Roux-en-Y reconstruction (RY) (ADTR group, n = 18 vs RY group, n = 37) were retrospectively compared to evaluate the efficacy and safety of the procedures. The results of the study demonstrated that ADTR was technically safe and feasible, offering an agreeable near-term quality of life, especially in terms of early recovery and the alleviation of reflux esophagitis. ADTR may be a worthwhile digestive tract reconstruction method for Siewert types II and III adenocarcinoma of the esophagogastric junction.
